Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ICU MedicalSTU:IC7 80 Gross Margin % is 42.61% as of Jun. 2026, which is 16% above its 10-year median of 36.58. GuruFocus rates STU:IC7 with a GF Score™ of 80/100 and a GF Value™ of €105.79 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 804 Medical Devices & Instruments companies, ICU Medical ranks worse than 69.4% on this metric.
The historical rank and industry rank for ICU Medical's Gross Margin % or its related term are showing as below:
STU:IC7'
s Gross Margin % Range Over the Past 10 Years
Min: 30.6 Med: 36.58 Max: 53.09
Current: 39.13
During the past 13 years, the highestGross Margin % of ICU Medical was 53.09%. The lowest was 30.60%. And the median was 36.58%.
STU:IC7's Gross Margin % is ranked worse than 69.4% of 804
companies
in the Medical Devices & Instruments industry
Industry Median: 52.26
vs STU:IC7: 39.13
ICU Medical had a gross margin of 42.61% for the quarter that ended in Jun. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for ICU Medical was -0.30% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
ICU Medical had a gross margin of 42.61% for the quarter that ended in Jun. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
ICU Medical Gross Margin % Related Terms
ICU Medical Gross Margin % Historical Data
* Premium members only.
The historical data trend for ICU Medical's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:IC7 vs NVST, MMSI, MMED: Gross Margin % Comparison
For the Medical Instruments & Supplies subindustry, ICU Medical's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ICU Medical Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, ICU Medical's Gross Margin % distribution charts can be found below:
* The bar in red indicates where ICU Medical's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
ICU Medical (STU:IC7) has a Gross Margin % of 42.61% as of Jun. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on ICU Medical and its competitors. This is 16% above median its historical median of 36.58. Over the past decade, ICU Medical's Gross Margin % has ranged from 30.60 to 53.09. According to the industry distribution chart, ICU Medical ranks #558 out of 804 companies in the Medical Devices & Instruments industry, placing it in the top 69.4%.
Is ICU Medical's Gross Margin % too high?
ICU Medical's current Gross Margin % of 42.61% is 16% above median its 10-year median of 36.58. Over the past 10 years, this metric has ranged from a low of 30.60 to a high of 53.09. The Medical Devices & Instruments industry median Gross Margin % is 52.26. ICU Medical's value of 42.61% is 18.5% below this industry median. Based on the distribution chart, ICU Medical ranks #558 out of 804 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, ICU Medical has a GF Score™ of 80/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does ICU Medical's Gross Margin % compare to NVST and MMSI?
According to the Medical Devices & Instruments industry distribution chart, ICU Medical ranks #558 out of 804 companies for Gross Margin %. This places ICU Medical in the lower half of its industry. The industry median Gross Margin % is 52.26. ICU Medical's value of 42.61% is 18.5% below this benchmark. Historically, ICU Medical's own Gross Margin % has ranged from 30.60 to 53.09 over the past decade. While the company's 10-year median is 36.58 vs. the industry median of 52.26, ICU Medical has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.26, based on 804 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ICU Medical's current Gross Margin % of 42.61% is 18.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on ICU Medical and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ICU Medical's current Gross Margin % is 42.61%, which is 16% above median its own 10-year median of 36.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ICU Medical stock overvalued right now?
Based on GuruFocus' analysis, ICU Medical (STU:IC7) is currently considered Significantly Overvalued. The stock's GF Value™ is €105.79, compared to a current price of €158.00 — trading 49.4% above its estimated fair value. The current Gross Margin % is 42.61%, which is 16% above median its 10-year median of 36.58 and 18.5% below the Medical Devices & Instruments industry median of 52.26. ICU Medical's overall GF Score™ is 80/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For ICU Medical (STU:IC7), the current Gross Margin % is 42.61% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ICU Medical (STU:IC7) Overvalued in 2026?
Based on GuruFocus' analysis, ICU Medical stock appears to be overvalued.
The current stock price of €158.00 is trading 49.4% above its estimated GF Value™ of €105.79.
GuruFocus considers ICU Medical to be Significantly Overvalued.
Key valuation signals for STU:IC7:
Gross Margin %: 42.61% (16% above median its 10-year median of 36.58)
GF Value™: €105.79 vs. price of €158.00 (49.4% above fair value)
Industry Position: 18.5% below the Medical Devices & Instruments median (#558 of 804)
No single metric tells the full story. See the STU:IC7 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.
80GF Score
Get the complete analysis for STU:IC7
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:IC7 has been successfully added to your 
